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Abstract
Background: It is not uncommon that a child with a febrile illness of unknown etiology is admitted to the hospital.
When the complete blood count reveals a pancytopenia, the diagnostic process can be a real challenge.
Case presentation: A 13-year girl of Arab-Berber descent presented with abdominal pain and fever after a holiday
in northwestern Morocco. A complete blood count revealed a pancytopenia and blood smear test results revealed
spirochetes. Borrelia hispanica was identified by sequencing the 16S ribosomal ribonucleic acid gene. Our patient
was treated with tetracyclines and during this treatment we saw full clinical and hematological recovery.
Conclusions: Borrelia hispanica is a known cause of tick-borne relapsing fever and is transmitted to humans
through the bite of soft ticks of the genus Ornithodoros (Alectorobius). Although the link between tick-borne
relapsing fever and thrombocytopenia has been documented, there are only a few case reports of tick-borne
relapsing fever presenting with pancytopenia. To the best of our knowledge, there is no previous report of Borrelia
hispanica presenting with pancytopenia.
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Background
Climate change has increased migrant influx and increas-
ing numbers of intercontinental travelers will cause higher
prevalence of relatively unknown parasitic diseases in
Western Europe. It is therefore not uncommon that a
child with a febrile illness of unknown etiology is admitted
to the hospital. The unfamiliarity of the pathology makes
the diagnostic process a real challenge, especially when
the presentation is unusual for an uncommon disease, like
the one we present here.
Case presentation
A 13-year old girl of Arab-Berber descent (Morocco)
presented to our emergency department because of
abdominal cramps and pain in the right and left iliac
fossa for 3 days, accompanied by vomiting and high
fever. One week before, she had returned from a 2-
month visit in northwestern Morocco. During her stay
in Morocco, she was residing in the house of a family
member. There was no contact with animals, no history
of a tick bite, and she did not visit any parks or forests.
She swam in the Mediterranean Sea and in a freshwater
swimming pool, but she never went swimming in nat-
ural freshwater resources. She had not been sick during
her stay and no skin rash was seen. Returning to
Belgium, the next day she developed lower abdominal
pain, diarrhea, vomiting, and high fever. After 4 days,
she presented to the emergency department of our
hospital.
Her medical history revealed a right-sided Bell’s palsy
in the previous year with a magnetic resonance imaging
(MRI) scan that showed a neuritis facialis, and a Borrelia
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serological test result that was negative. She had recur-
rent episodes of herpes labialis.
A physical examination at presentation showed a
mildly sick girl with stable cardiovascular and respiratory
parameters, without fever. She had a herpes labialis le-
sion on her lower lip. Her heart and lung auscultation
were normal. An abdominal investigation showed
normal bowel sounds and diffuse pain by palpation,
most pronounced in the right and left fossa. The initial
complete blood count showed a mild, Coombs-negative,
normocytic anemia with a hemoglobin of 10.4 g/dL
(normal 12.1–14.6 g/dL), reticulocytes 5.8/1000 red
blood cells (RBC) (normal 8–22/1000 RBC), leukocytes
of 4.7 × 10E9/L (normal 4.5–10.7 × 10E9/L) with a mild
neutropenia and mild monocytosis, and thrombocytes of
55 × 10E9/L (normal 188–429 × 10E9/L), with C-
reactive protein of 210 mg/L (normal ≤ 5 mg/L). There
were no signs of hemolysis with normal lactate dehydro-
genase and bilirubin. An abdominal ultrasound scan was
normal, but without visualization of the appendix. A urine
investigation and thoracic X-ray showed no signs of infec-
tion. Since appendicitis could not be ruled out, an append-
ectomy was done immediately; however, the appendix was
not inflamed on visualization. The next day, the complete
blood count revealed a more pronounced pancytopenia
(see Fig. 1) and the blood smear test result showed some
spirochetes. Therefore, the differential diagnosis was nar-
rowed to leptospirosis and borreliosis (see Fig. 2), making
the latter more likely given the microscopic and morpho-
logical characteristics of the spirochetes. Serological test
results for leptospirosis immunoglobulin M and G (IgM
and IgG) and Borrelia burgdorferi were negative, as well as
for ehrlichiosis, anaplasmosis, babesiosis, Rocky Mountain
spotted fever and other parasitic infections. The diagnosis
of tick-borne relapsing fever was suspected and treatment
with tetracycline (intravenous, 20–40 mg/kg/day in four
doses) was initiated. Blood and urine cultures did not
reveal growth. Sequencing of 1500 bp of the 16S riboso-
mal ribonucleic acid (rRNA) gene, of which 872 bp was
analyzable [on a Genetic Analyzer ABI 3730XL (Applied
Biosystems, Invitrogen Life Technologies, Carlsbad, CA,
USA), with the BigDye Terminator kit (Applied Biosys-
tems) using a home-brew method], confirmed our diagno-
sis. Basic Local Alignment Search Tool (BLAST) analysis
of the consensus sequence revealed 100% identity with the
first 13 propositions representing Borrelia hispanica 16s
ribosomal RNA gene sequences. The closest match to the
next Borrelia species was observed with several Borrelia
crocidura strains showing 99% identity. The nucleotide se-
quence was submitted to GenBank and obtained the ac-
cession KY285287. Our patient was treated with a
combination of ceftriaxone (2 g/day in 1 dose, for 3 days)
Fig. 1 Blood count at diagnosis and response to therapy. Left y-axis: thrombocytes. Right y-axis: white blood cell count, hemoglobin and reticulocytes.
X-axis: time in days
Fig. 2 Blood smear test result revealing spirochetes with irregular,
wide, open coils suggesting a Borrelia infection
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and doxycycline (2 mg/kg/day in 1 dose, for 14 days) during
which we saw a full clinical and hematological recovery.
Discussion
Spirochetes are Gram-negative bacteria with a double
membrane and a helicoidal structure. Flagella are
present, allowing the spirochete to rotate as it moves.
They are divided into three families (Leptospiraceae,
Brachyspiraceae and Spirochaetaceae) and are respon-
sible for several diseases in humans, for example lepto-
spirosis, Lyme disease, relapsing fever, syphilis and
intestinal spirochaetosis. Tick-borne relapsing fever
(TBRF) is an infection caused by spirochetes of the
genus Borrelia, transmitted to humans through the bite
of soft ticks (Ornithodoros species). It is caused by at
least 16 distinct Borrelia species throughout the world
[1, 2]. Borrelia species are Gram-negative helical bacteria
that normally measure 0.2 to 0.5 μm in width and 5 to
20 μm in length. They are very hard to culture, but
visible with dark-field and light microscopy. They have
the corkscrew shape typical of all spirochetes [3]. Each
Borrelia species associated with relapsing fever appear to
be specific to its tick vector [2].
First signs of TBRF are usually observed between 4
and 14 days after the tick bite, with an acute onset of
high fever, headache, arthralgia, myalgia, neck stiffness,
and abdominal complaints [4]. Case fatality rate is 2–5%
without treatment. Severity depends on Borrelia species,
inoculum density, and underlying medical condition.
Children and women appear to have a more intense
course of disease [5]. The primary episode usually lasts 3
days and is followed, after a fever-free interval of 7 days,
by multiple other alternating episodes, often shorter and
milder. During the febrile periods, numerous Borreliae
are circulating in the blood and diagnosis can be made
by observation of spirochetes on thin- or thick-blood
smears with dark-field microscopy or with conventional
microscopy after Giemsa, Wright or Diff-Quick staining
[5, 6].
Borrelia cultures have not been widely used due to the
low sensitivity range. Molecular methods are used with
increasing frequency and offer the possibility of genus
and even species identification [7]. As such, Borrelia
hispanica has been detected and isolated from speci-
mens obtained in Northern Africa and Southern Europe,
including Morocco, Spain, Portugal, Greece and Cyprus
and is held responsible for 20.5% of patients with unex-
plained fever in northwestern Morocco [1, 8]. The
disease caused by Borrelia hispanica is one of the less
severe TBRFs, with neurological signs in less than 5% of
cases [9]. The preferred treatment for TBRF is tetracyc-
line or doxycycline. When contraindicated, erythromycin
is the alternative. In very sick patients (with neurologic
symptoms) intravenous ceftriaxone can be added. No
exact data is available in the literature about the associ-
ation of TBRF and thrombocytopenia at presentation,
but it is not uncommon [4]. In contrast, TBRF present-
ing with pancytopenia is rare and only reported in a few
case reports. Badger et al. described an infection with
the recently discovered Borrelia miyamotoi and pancyto-
penia, and Chowdri et al. presented a case of a 59-year-
old woman with borreliosis and pancytopenia. Her bone
marrow was packed with Borrelia hermsii [3, 10].
Pancytopenia is a common manifestation of many tick-
borne diseases; however the pathogenesis is poorly
understood, possibly resulting from decreased bone
marrow production, consumption due to widespread
endothelial damage or due to immune-mediated de-
struction. Data on the prevalence of thrombocytopenia,
neutropenia or anemia with Borrelia hispanica TBRF is
not available and to the best of our knowledge, no
reports of Borrelia hispanica presenting with pancyto-
penia have been published. Borrelia hispanica is trans-
mitted through soft ticks, making co-infection of other
tick-borne bacterial diseases like anaplasmosis or
babesiosis, which are known to present with cytopenias,
but transmitted through hard ticks of the Ixodes species,
unlikely.
Conclusions
We report a case of a patient with Borrelia hispanica
tick-borne relapsing fever presenting with abdominal
pain, fever and pancytopenia. TBRF is a rare disease in
Europe. It is found in some Mediterranean countries, and
is a frequent cause of fever in northwestern Morocco.
Therefore it should be in the differential diagnosis of trav-
elers returning from these areas presenting with unex-
plained fever. Although the link between TBRF and
thrombocytopenia has been documented, there are only a
few cases of TBRF presenting with pancytopenia. To the
best of our knowledge, this is the first report of Borrelia
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